Sun Pharmaceutical Industries Ltd.

is India's largest pharmaceutical company with a global presence in generic and specialty medicines across multiple therapeutic areas. The company reported quarterly revenues of Rs. 13,851.40 crores with a net profit of Rs. 2,292.87 crores, showing stable performance in the pharmaceutical sector. Sun Pharma has a strong pipeline of generic drugs and growing specialty medicine business, with significant exposure to the US market. The company faces regulatory challenges, pricing pressures in key markets, and competition from other generic drug manufacturers.